Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Sun Pharmaceutical Industries Limited - Karkhadi
WARNING LETTER
•Sun Pharmaceutical Industries Limited - Karkhadi•November 16, 2013

Sun Pharmaceutical Industries Limited - Karkhadi – FDA Warning Letter, Nov 16, 2013

Record Details

On May 7, 2014, the FDA issued a Warning Letter to Sun Pharmaceutical Industries Limited - Karkhadi, India, following a November 13-16, 2013, inspection. The inspection revealed significant violations of CGMP regulations for finished pharmaceuticals (21 CFR Parts 210 and 211) and deviations from CGMP for active pharmaceutical ingredients (APIs), rendering their products adulterated.

Key violations include: 1. **Incomplete Laboratory Records and Data Manipulation:** The firm failed to maintain complete raw data for analyses, including sample identification, full raw data (graphs, electronic files), test methods, calculations, and proper sign-offs. "Unofficial testing" was frequently performed, with results discarded and "official" passing results reported. Examples include deleted HPLC and GC chromatograms (5,301 deleted HPLC files found), some showing out-of-specification (OOS) results that were not investigated. 2. **Failure to Control Computer Systems:** The GC instrument software allowed file deletion without an audit trail, enabling data manipulation and overwriting of deleted files with identical names, making traceability impossible. 3. **Failure to Maintain Records:** Approximately 10 waste bags contained torn or destroyed CGMP records, including calibration checks, CAPA records (some without official copies), and preventive maintenance forms. This indicates a lack of oversight and systemic record destruction. 4.

Company
Sun Pharmaceutical Industries Limited - Karkhadi
Inspection date
November 16, 2013
Product type
Drugs
Office
Center for Drug Evaluation and Research
People
  • Mukesh R. Patel
  • Michael D. Smedley
View Company Profile

ID · 92b301af-c0b0-4b1e-8444-55defc1a85b4

Violation Codes9
21 U.S.C. 351(a)(2)(B)21 CFR 21021 CFR 21121 CFR 211.68(b)21 CFR 211.180(a)21 CFR 211.25(a)FD&C Act 801(a)(3)21 U.S.C. 381(a)(3)FD&C Act 501(a)(2)(B)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Sun Pharmaceutical Industries Limited - Karkhadi
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.